A major global survey has now confirmed that one in three adults worldwide meet diagnostic criteria for a functional bowel disorder (FBD). That equates to roughly 1.7 billion people living with chronic digestive symptoms such as bloating, abdominal pain, constipation, diarrhoea, or unpredictable bowel habits.
The findings, reported by Medscape and based on the Rome Foundation Global Epidemiology Study, are striking, but for many practitioners, not surprising. Digestive symptoms are among the most common reasons people seek nutritional, integrative, or functional medical support. Yet despite their prevalence, these symptoms often remain poorly explained by routine medical tests.
This expanding recognition of FBDs highlights a clear need for comprehensive, personalised assessment tools that help clinicians understand the multifactorial drivers behind each patient’s symptoms. This is precisely where FoodPrint® and the new GutDetective® biomarker panel can work together to provide a deeper, more actionable picture.
What the New Report Reveals
1. Functional bowel disorders are extremely common
FBDs affect around 33% of adults, with similar prevalence across all regions. This makes FBDs one of the most widespread chronic health conditions globally, far more common than asthma, diabetes or heart disease.
2. IBS is only part of the picture
Although IBS is well-known, it accounts for only ~4% in this dataset. Other FBD subtypes include:
- Functional constipation
- Functional diarrhoea
- Functional bloating/distension
- Unspecified FBD
Collectively, these represent a much larger population of symptomatic individuals who often struggle to find answers.
3. Symptoms extend beyond the gut
Those with FBDs reported:
- Higher levels of fatigue
- Pain syndromes
- Psychological distress
- Lower quality of life
- Higher healthcare utilisation
This pattern aligns closely with gut–brain axis dysfunction, immune activation, barrier impairment, and microbiome disturbances.
4. Standard tests are typically normal
Most people with FBDs do not show structural disease, inflammation or pathology on routine medical investigations. This gap between symptoms and standard test results fuels frustration and uncertainty for both patients and clinicians.
Why a Combined Testing Strategy Makes Sense
FBDs are multifactorial. Symptoms may be driven by a combination of:
- Immune reactivity to foods
- Microbiome imbalance
- Low-grade inflammation
- Impaired digestive function
- Barrier dysfunction (leaky gut)
- Stress and neuroendocrine factors
No single test explains everything, and this is precisely why FoodPrint® and GutDetective® complement each other so well.
FoodPrint® — Personalised IgG Food-Sensitivity Mapping
FoodPrint® measures IgG antibodies to a broad range of foods, allowing practitioners to identify heightened immune recognition that may be contributing to symptoms.
Where FoodPrint® adds clinical value:
- Identifies food-related immune activation that may drive bloating, pain, or irregular bowel habits
- Helps prioritise foods to eliminate or rotate, reducing guesswork
- Supports personalised nutrition rather than broad, restrictive diets
- Often improves patient engagement and compliance by offering objective data
- Integrates well with gut microbiome and inflammatory markers
FoodPrint® is especially useful for patients who report inconsistent, delayed, or difficult-to-identify food triggers, a hallmark of IgG-mediated responses.
GutDetective® — Objective Biomarkers for Gut Function
GutDetective® expands your ability to understand why digestive symptoms persist by measuring clinically relevant biomarkers, such as:
- Faecal Calprotectin – differentiating inflammatory vs. functional disorders
- Pancreatic Elastase – assessing digestive enzyme output
- Alpha-1 Antitrypsin – intestinal permeability marker
Where GutDetective adds clinical value:
- Detects hidden inflammation or barrier dysfunction
- Identifies maldigestion due to pancreatic insufficiency
- Highlights immune imbalance or mucosal fragility
- Helps rule out organic disease when symptoms overlap with FBDs
- Provides objective markers to track progress over time
Together, these markers provide a mechanistic understanding of a patient’s digestive health, essential for targeted intervention.
Why Combining FoodPrint® and GutDetective® Works So Well
FBDs are complex. One person’s bloating may be microbiome-driven; another’s may be barrier dysfunction; another’s may be IgG-mediated food reactivity, or a mixture of all three.
Using FoodPrint® and GutDetective® together allows practitioners to:
Identify food-related immune triggers (FoodPrint®)
And
Detect underlying physiological imbalances (GutDetective®)
This two-layered approach delivers:
- More accurate clinical insights
- More personalised dietary planning
- Better patient outcomes
- More confident decision-making
- A clearer demonstration of progress over time
For the many individuals living with these widespread gut disorders, this joined-up testing strategy can be transformative.
Conclusion: A Global Problem Needs Personalised Solutions
With one in three adults now recognised as living with a functional bowel disorder, digestive symptoms are not a niche issue, they are a global health challenge.
By combining FoodPrint® IgG food-sensitivity testing with the GutDetective® biomarker panel, practitioners gain a comprehensive, personalised, and clinically relevant framework for assessing and managing these conditions.
In a landscape where symptoms are common, distressing, and often unexplained, offering clearer answers is one of the most powerful things we can do for patients.
